EC
ECOR.KL
—
Bursa Malaysia
Diversified Medical Equipment & Supplies
Ecor.Kl
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
—
P/E
—
EV / Rev
—
Div yield
7,14 %
Op margin
8,7 %
ROE
2,4 %
Net margin
2,5 %
Debt / equity
0,27
Beta
—
52w range
—
Volume
3,2k
Day range
$8,65–$9,68
Prev close
$8,91
Open
$8,95
Next earnings
—
Ex-dividend
—
TR 1Y
—
About
ECOR.KL is a construction supplies and fixtures company that generates revenue primarily through the production and sale of building materials and related products.
Business. electroCore, Inc. (ECOR.O) is a healthcare services and equipment company that operates within the medical equipment, supplies, and distribution industry. The firm generates revenue primarily through the sale of products. Headquartered in the United States, the company is listed on the NASDAQ stock exchange. Specific operating segments and geographic breakdowns are not disclosed in the available data.
Classification99 %
SectorHealth Care
Industry groupDiversified Medical Equipment & Supplies
Generated · model-assisted
Sell-side consensus
BUY5 analysts
5 buy0 hold0 sell
Avg 12m price target19,80
Analyst recommendations
5 analysts · consensus BuyBuy5
Hold0
Sell0
12-month price target
19,80
Consensus of sell-side coverage.
At a glance
Score
—
not yet scored
Valuation
—
valuation pending
Analysts→
Buy
5 analysts · indicative
Ownership→
Geode Capital Management, L.L.C.
largest disclosed fund holder
Profitability→
2,4 %
return on equity
Quality
—
not yet scored
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
— missing data
News & coverage
0Sector rotation
Sector1D1Mvs mkt
Materials+2,3 %+6,6 %+1,7 %
Communication Services+2,2 %−5,5 %+1,6 %
Energy+0,6 %+3,3 %+0,0 %
Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
Information Technology+0,6 %+6,7 %+0,0 %
Consumer Discretionary+0,4 %+7,6 %−0,2 %
Financials−0,3 %−2,8 %−0,9 %
Consumer Staples−0,4 %+2,5 %−1,0 %
Real Estate−0,7 %+10,9 %−1,3 %
Industrials−1,9 %−3,1 %−2,5 %
Utilities−1,9 %+28,2 %−2,5 %
Developing storylines
No tracked sagas currently linked to ECOR.KL. Browse all sagas →
Analysis
AI analysis
Generated · analysis pipeline · tier hybrid · as of 2026-08-04
↑ At a glance
Opportunity
— missing data
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
— missing data
Signals & dispatch
peak dispatch · —
Composite-score breakdown
Synthesis
Business
electroCore, Inc. (ECOR.O) is a healthcare services and equipment company that operates within the medical equipment, supplies, and distribution industry. The firm generates revenue primarily through the sale of products. Headquartered in the United States, the company is listed on the NASDAQ stock exchange. Specific operating segments and geographic breakdowns are not disclosed in the available data.
Classification99 %
SectorHealth Care
Industry groupDiversified Medical Equipment & Supplies
AI synthesis
GENERATEDECOR.KL has a liquidity position that is characterized by a current ratio of 2.61, indicating that the company has sufficient current assets to cover its current liabilities more than twice over. However, the company's free cash flow is negative at -6050040.0 MYR, which suggests that it is spending more on capital expenditures than it is generating in operating cash flow. The company's cash and equivalents amount to 17723700.0 MYR, but this is offset by long-term debt of 30977180.0 MYR, resulting in a net cash position that is negative after subtracting total debt.
In terms of profitability, ECOR.KL has a return on equity of 2.38% and a return on assets of 1.41%, which are below the industry median for the Construction Supplies & Fixtures sector. The company's operating income of 9651940.0 MYR and net income of 2775300.0 MYR indicate a relatively low level of profitability, which may be a concern for investors looking for strong returns.
The company's revenue is concentrated in the construction supplies and fixtures segment, with no significant geographic diversification reported in the available data. This concentration may expose the company to risks associated with the cyclical nature of the construction industry and regional economic fluctuations.
The growth trajectory of ECOR.KL is not clearly defined in the available data, as there are no specific numeric deltas provided for the current or next fiscal year. However, the company's capital expenditure of -7928690.0 MYR suggests that it is investing in its operations, which could be a sign of future growth.
The risk assessment for ECOR.KL indicates a medium level of liquidity risk and a low level of dilution risk. The key flag of a negative net cash position after subtracting total debt is a concern for liquidity, but the company's low dilution risk suggests that there is little immediate threat from share issuance.
Recent events and filings for ECOR.KL are not detailed in the provided data, so it is not possible to comment on specific recent developments that may have impacted the company's financial position or strategic direction.
Key takeaways
- ECOR.KL has a strong current ratio but a negative free cash flow, indicating potential liquidity challenges.
- The company's return on equity and return on assets are below the industry median, suggesting lower profitability.
- Revenue is concentrated in the construction supplies and fixtures segment, with no significant geographic diversification.
- The company is investing in capital expenditures, which may indicate a growth strategy.
- The risk assessment highlights a medium liquidity risk and a low dilution risk.
- "margin_outlook_rationale": "The company's margin outlook is uncertain due to its low return on equity and return on assets, which are below the industry median.",
Bull / Bear case
Generated · model-assisted— missing data
In focus — financials by report
Valuation
Market price
$0,25
Market cap
—
Enterprise valueⓘ
—
P/Eⓘ
—
Non-GAAP P/Eⓘ
—
EV / Revenueⓘ
—
EV / Op incomeⓘ
—
EV / OCFⓘ
—
P / Bⓘ
—
P / Tangible bookⓘ
—
Tangible book
$116.6M
Net cashⓘ
-$13.3M
Current ratioⓘ
2.6
Debt / equityⓘ
0.3
ROAⓘ
1.4%
ROEⓘ
2.4%
Cash conversionⓘ
203.0%
CapEx / revenueⓘ
-7.1%
SBC / revenueⓘ
—
Dilution ratioⓘ
0.0%
Revenue by segment
Business relationships
— missing data
Supply chain
— missing data
Peer comparison
Peer comparison8 peers · vs ECOR · multiples and returns
AB
ABT—
Abbott Laboratories
$107,13
187,2B USDP/E
26,3x
— vs self
Div yield
2,4 %
— vs self
ROE
12,5 %
-804,7 vs self
MD
MDT—
Medtronic PLC
$86,19
110,3B USDP/E
21,4x
— vs self
Div yield
3,4 %
— vs self
ROE
9,7 %
-807,5 vs self
MD
MDLN—
MEDLINE INC.
$40,47
53,2B USDP/E
202,6x
— vs self
Div yield
—
— vs self
ROE
—
— vs self
SY
SYK—
Stryker Corp
$341,20
131,8B USDP/E
38,0x
— vs self
Div yield
—
— vs self
ROE
13,5 %
-803,7 vs self
BD
BDX—
Becton Dickinson And Co
$170,21
48,4B USDP/E
25,6x
— vs self
Div yield
2,8 %
— vs self
ROE
7,0 %
-810,3 vs self
HS
HSIC—
Henry Schein Inc
$88,21
10,1B USDP/E
80,5x
— vs self
Div yield
—
— vs self
ROE
3,0 %
-814,2 vs self
BA
BAX—
Baxter International Inc
$28,10
14,5B USDP/E
—
— vs self
Div yield
2,3 %
— vs self
ROE
-15,4 %
-832,6 vs self
SO
SOLV—
SOLVENTUM CORPORATION
$76,83
13,3B USDP/E
8,6x
— vs self
Div yield
—
— vs self
ROE
30,8 %
-786,4 vs self
Market position
Stress test
— missing data
Predictor forecast
Next quarternear-term
Earnings · next quarterconf 45 %
EPS
Consensus EPS
-1,21
Predicted surprise
+0,00
Beat probability
45 %
Analysts
5
Other metrics
Revenue
—
no estimate
Segment revenue
—
no estimate
Margin
—
no estimate
Segment margin
—
no estimate
as of 2026-05-16 · Earnings Surprise V1
Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
Probabilistic model output — not investment advice. · generated 2026-08-04
Options
— missing data
Short squeeze
— missing data
Earnings-call key lines
— missing data
Estimate revisions
consensus EPS · 26-week trend— missing data
Sell-side observations
Low$12,00
Mean$19,80
Median$22,00
High$25,00
Spot$0,25
+7820.0 %implied to mean12-month sell-side price targets · ▲ spot
Themes
— missing data
ESG
— missing data
Risk factors
Dilution riskLow
Liquidity riskMedium
Filing-based flags
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Op Margin8,7 %Above median
Net Margin2,5 %Above median
ROE2,4 %Above median
Capex / Rev-7,1 %Bottom quartile
D/E0,27Above median
Cash Conv2,03Above P75
Corporate actions / M&A
— missing data
FX exposure
— missing data
Comparable transactions
— missing data
Derivatives & instruments
Derivative transactions
Net acquired 42 055 sh2 exercises1 insiders
- Director · Warrants to Purchase Common Stock → Common StockAcquired 19 252 @ $6,43exercise · 2026-03-19
- Director · Warrants to Purchase Common Stock → Common StockAcquired 22 803 @ $4,35exercise · 2026-03-19
Actions
Ask Handelsavisen
— missing data
Data sources
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
How metrics are computed
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
Source documents
- ECOR.KL Market data — financials · 2026-05-27
Ownership & reference
Top holders
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2025-12-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2024-06-300,00 %$0M
- Brokerage Firms · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
Insider activity
Net selling4 buys · 6 sellsnet -$610K9 insiders · last 365d
- CFO and Interim President · Common StockSold 6 667 @ $9,00$60K · 2026-05-28
- CFO and Interim President · Common StockSold 3 000 @ $6,50$20K · 2026-05-22
- Director · Common StockBought 9 992 @ $5,99$60K · 2026-05-21
- Director · Common StockOther 8 @ $5,98$48 · 2026-05-20
- Former Officer & Director · Common StockSold 80 000 @ $6,80$544K · 2026-04-23
- Chief Operating Officer · Common StockOther 70 000 · 2026-04-13
- Former Officer and Director · Common StockSold 16 072 @ $6,02$97K · 2026-04-10
- CFO and Interim President · Common StockOther 45 000 · 2026-04-01
- Director · Common StockOther 19 252 @ $6,43$124K · 2026-03-19
- Director · Common StockOther 22 803 @ $4,35$99K · 2026-03-19
- Chief Financial Officer · Common StockOther 25 000 · 2026-01-26
- Director, Chief Executive Officer · Common StockOther 20 375 @ $7,47$152K · 2026-01-26
- Director, Chief Executive Officer · Common StockOther 26 000 · 2026-01-26
- Chief Financial Officer · Common StockOther 2 889 · 2026-01-26
- Chief Financial Officer · Common StockSold 2 500 @ $5,05$13K · 2025-12-04
- Director, Chief Executive Officer · Common StockBought 1 000 @ $4,84$5K · 2025-12-02
- Chief Financial Officer · Common StockSold 2 166 @ $6,18$13K · 2025-11-12
- Director · Common StockOther 30 549 · 2025-09-10
- Director · Common StockOther 19 011 · 2025-09-02
- Director · Common StockOther 26 615 · 2025-09-02
- Director · Common StockOther 19 011 · 2025-09-02
- Director · Common StockOther 19 011 · 2025-09-02
- Director · Common StockOther 19 011 · 2025-09-02
- Director, Chief Executive Officer · Common StockBought 1 000 @ $4,23$4K · 2025-08-11
- Director · Common StockBought 15 000 @ $4,47$67K · 2025-08-11
Short positioning
367.6Kshares short+80.0% vs prior
3.45days to cover
34.8%short of daily vol
264fails-to-deliver
as of 2026-07-15 · short-interest report (free)
Geographic breakdown
— missing data
Listings · one canonical issuer
all listings resolve to the canonical
ECOR.KLCanonical
Bursa Malaysia · USD
Intel & risk
peak dispatch · —
OSINT findings
Dilution riskLow
Liquidity riskMedium
Net cash is negative after subtracting total debt.
Evidence & claims
From filings & derived data- Current ratio (FY 2025-12-31): 1.38xDerived (calculated)
- Return on assets (FY 2025-12-31): -74.8%Derived (calculated)
- Return on equity (FY 2025-12-31): 817.2%Derived (calculated)
- Net margin (FY 2025-12-31): -43.6%Derived (calculated)
- Gross margin (FY 2025-12-31): 86.8%Derived (calculated)
- Debt-to-equity (FY 2025-12-31): -11.92xDerived (calculated)
- Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): 90.1%Derived (calculated)
- Revenue (YoY) (2025-12-31 vs 2024-12-31): 27.2%Derived (calculated)
- Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): -17.8%Derived (calculated)
- EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): -3.8%Derived (calculated)
- Operating income (YoY) (2025-12-31 vs 2024-12-31): -8.1%Derived (calculated)
- Cost of revenue (YoY) (2025-12-31 vs 2024-12-31): 12.1%Derived (calculated)
- EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): -3.8%Derived (calculated)
- Total liabilities (YoY) (2025-12-31 vs 2024-12-31): 57.6%Derived (calculated)
- Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): -122.7%Derived (calculated)
- Capex (YoY) (2025-12-31 vs 2023-12-31): -68.0%Derived (calculated)
- Total assets (YoY) (2025-12-31 vs 2024-12-31): -8.8%Derived (calculated)
- Gross profit (YoY) (2025-12-31 vs 2024-12-31): 29.9%Derived (calculated)
- Net income (YoY) (2025-12-31 vs 2024-12-31): -17.5%Derived (calculated)
- Pre-tax income (annual): USD -13.96MSEC XBRL filing
- EPS (diluted) (annual): USD-PER-SHARES -2SEC XBRL filing
- Total operating expenses (annual): USD 40.94MSEC XBRL filing
- Total liabilities (annual): USD 20.38MSEC XBRL filing
- Cash & equivalents (annual): USD 7.04MSEC XBRL filing
Showing 24 of 60 surfaced claims.
Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.
The Thread
Everything we know, in order2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
2026-05-28 00:00 UTCINSIDER4 insider transactions — 2026-05 · $139k gross
2026-05-28INSIDERLev Joshua S. sold 6.7k sh — CFO and Interim President ~$60k
2026-05-22INSIDERLev Joshua S. sold 3.0k sh — CFO and Interim President ~$20k
2026-05-21INSIDERErrico Thomas J. bought 10.0k sh — Director ~$60k
2026-05-20INSIDERErrico Thomas J. transacted 8 sh — Director ~$0k
2026-04-23INSIDERGoldberger Daniel S sold 80.0k sh — Former Officer & Director ~$544k
2026-04-13 00:00 UTCINSIDER3 insider transactions — 2026-04
2026-04-13INSIDERFox Michael transacted 70.0k sh — Chief Operating Officer
2026-04-10INSIDERGoldberger Daniel S sold 16.1k sh — Former Officer and Director ~$97k
2026-04-01INSIDERLev Joshua S. transacted 45.0k sh — CFO and Interim President
2026-03-19 00:00 UTCINSIDER4 insider transactions — 2026-03 · net buy $223k 2 derivative
2026-03-19INSIDERErrico Thomas J. transacted 19.3k sh — Director ~$124k
2026-03-19INSIDERErrico Thomas J. transacted 22.8k sh — Director ~$99k
2026-03-19INSIDERErrico Thomas J. acquired 22.8k sh Warrants to Purchase Common Stock — Director
2026-03-19INSIDERErrico Thomas J. acquired 19.3k sh Warrants to Purchase Common Stock — Director
2026-01-26 00:00 UTCINSIDER4 insider transactions — 2026-01 · net buy $152k
2026-01-26INSIDERLev Joshua S. transacted 25.0k sh — Chief Financial Officer
2026-01-26INSIDERGoldberger Daniel S transacted 20.4k sh — Director, Chief Executive Officer ~$152k
2026-01-26INSIDERGoldberger Daniel S transacted 26.0k sh — Director, Chief Executive Officer
2026-01-26INSIDERLev Joshua S. transacted 2.9k sh — Chief Financial Officer
2025-12-04 00:00 UTCINSIDER2 insider transactions — 2025-12
2025-12-04INSIDERLev Joshua S. sold 2.5k sh — Chief Financial Officer ~$13k
2025-12-02INSIDERGoldberger Daniel S bought 1.0k sh — Director, Chief Executive Officer ~$5k
2025-11-12 00:00 UTCINSIDER1 insider transaction — 2025-11
2025-11-12INSIDERLev Joshua S. sold 2.2k sh — Chief Financial Officer ~$13k
2025-09-10 00:00 UTCINSIDER6 insider transactions — 2025-09
2025-09-10INSIDERBonfiglioli Elena transacted 30.5k sh — Director
2025-09-02INSIDERPATTON THOMAS M transacted 19.0k sh — Director
2025-09-02INSIDERErrico Thomas J. transacted 26.6k sh — Director
Showing the 40 most recent of 48 entries.
The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04
Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data
Premium coverage